Rob R. Ruijtenbeek
Corporate Officer/Principal at PamGene International BV
Profile
Rob R.
Ruijtenbeek is currently the Vice President-Biological Sciences at PamGene International BV since 2001.
He previously held the same position at PamGene BV.
He also worked as a Principal at the University of Leiden.
Dr. Ruijtenbeek earned his doctorate degree from the University of Utrecht in 2001.
Rob R. Ruijtenbeek active positions
Companies | Position | Start |
---|---|---|
PamGene International BV
PamGene International BV Pharmaceuticals: MajorHealth Technology PamGene is a biomarker company, focused on opening up new opportunities for the development of Personalized Medicine (pre-clinical, translational and clinical). Most of PamGene's projects are in oncology and many of these involve medicines that inhibit or modulate cellular kinases and kinase pathways. The firm collaborators apply its technologies for biomarker research in several other diseases and fields of expertise such as the Central Nervous System, the Cardiovascular area, Immunology and Obesity. PamGene's technology offers a faster and lower risk route for discovery and development of clinically useful biomarkers and uses cell lines and retrospective patient sample collection testing. | Corporate Officer/Principal | 2000-12-31 |
Former positions of Rob R. Ruijtenbeek
Companies | Position | End |
---|---|---|
University of Leiden | Corporate Officer/Principal | - |
PamGene BV
PamGene BV Pharmaceuticals: MajorHealth Technology PamGene BV provides biopharmaceutical products and clinical settings. It also provides PamChip biomarkers, such as tyrosine kinases, serine/threonine kinases, nuclear receptors, and reagent kits. The firm provides BioNavigator, a software tool for interpretation of PamChip measurements, as well as for performing data analysis for various PamChip experiments; and Evolve that enables data capture and analysis, as well as for the export of data into third party software formats. The company was founded by Tim Kievits in December 1999 and is headquartered in 's-Hertogenbosch, the Netherlands. | Chief Tech/Sci/R&D Officer | - |
Training of Rob R. Ruijtenbeek
University of Utrecht | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
PamGene BV
PamGene BV Pharmaceuticals: MajorHealth Technology PamGene BV provides biopharmaceutical products and clinical settings. It also provides PamChip biomarkers, such as tyrosine kinases, serine/threonine kinases, nuclear receptors, and reagent kits. The firm provides BioNavigator, a software tool for interpretation of PamChip measurements, as well as for performing data analysis for various PamChip experiments; and Evolve that enables data capture and analysis, as well as for the export of data into third party software formats. The company was founded by Tim Kievits in December 1999 and is headquartered in 's-Hertogenbosch, the Netherlands. | Health Technology |
PamGene International BV
PamGene International BV Pharmaceuticals: MajorHealth Technology PamGene is a biomarker company, focused on opening up new opportunities for the development of Personalized Medicine (pre-clinical, translational and clinical). Most of PamGene's projects are in oncology and many of these involve medicines that inhibit or modulate cellular kinases and kinase pathways. The firm collaborators apply its technologies for biomarker research in several other diseases and fields of expertise such as the Central Nervous System, the Cardiovascular area, Immunology and Obesity. PamGene's technology offers a faster and lower risk route for discovery and development of clinically useful biomarkers and uses cell lines and retrospective patient sample collection testing. | Health Technology |
- Stock Market
- Insiders
- Rob R. Ruijtenbeek